GE Healthcare Ireland Limited Provisional
FDA Flags (2)
Class II RecallApr 2026
GE Healthcare Ireland Limited
GE Healthcare Omnipaque (iohexol) Injection, 350 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough
Classification: Class II
Class II RecallApr 2026
GE Healthcare Ireland Limited
GE Healthcare Omnipaque (iohexol) Injection, 300 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough
Classification: Class II